Cargando…
Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial
We investigated the usefulness and effectiveness of tele-rehabilitation on exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A randomized study was carried out, including stable patients with IPF for 3 months of tele-rehabilitation: video and chat consultations with a physiothe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508000/ https://www.ncbi.nlm.nih.gov/pubmed/34639313 http://dx.doi.org/10.3390/ijerph181910016 |
_version_ | 1784581994161635328 |
---|---|
author | Cerdán-de-las-Heras, Jose Balbino, Fernanda Løkke, Anders Catalán-Matamoros, Daniel Hilberg, Ole Bendstrup, Elisabeth |
author_facet | Cerdán-de-las-Heras, Jose Balbino, Fernanda Løkke, Anders Catalán-Matamoros, Daniel Hilberg, Ole Bendstrup, Elisabeth |
author_sort | Cerdán-de-las-Heras, Jose |
collection | PubMed |
description | We investigated the usefulness and effectiveness of tele-rehabilitation on exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A randomized study was carried out, including stable patients with IPF for 3 months of tele-rehabilitation: video and chat consultations with a physiotherapist and workout sessions with a virtual physiotherapist agent (VAPA). Moreover, 6-min walk test distance (6MWTD), forced vital capacity (FVC), diffusion capacity for carbon monoxide (DLCO), 7 days pedometry, Saint George Respiratory Questionnaire for interstitial lung disease, The King’s Brief Interstitial Lung Disease Questionnaire, and General Anxiety Disorder 7 Questionnaire were tested before and after 3 months of tele-rehabilitation, as well as after 3 and 6 months follow-up. Patient satisfaction and adherence were also measured for tele-rehabilitation with VAPA. Twenty-nine patients aged 70.9 ± 8.6 years, male 72.4%, FVC% 83.5 ± 17.7, DLCO% 50.6 ± 13.0, 6MWTD 468.4 ± 14.8 were included. Fifteen patients were randomized to tele-rehabilitation with VAPA and 14 to the control group. Differences in 6MWTD between groups were at baseline (+10 m (p = 0.11)) and after 3 (+39.5 m (p = 0.03)), 6 (+34.3 m (p = 0.02)), and 9 months (+40.5 m (p = 0.15)) follow-up. No difference was observed in pedometry and quality of life. Adherence was above 63%. Patient satisfaction was high. Tele-rehabilitation with VAPA appears to be useful in patients with IPF. Exercise capacity was better at follow up at 3 and 6 months compared with the control group. There was no change in quality of life or pedometry. Adherence and patient satisfaction were all high. |
format | Online Article Text |
id | pubmed-8508000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85080002021-10-13 Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial Cerdán-de-las-Heras, Jose Balbino, Fernanda Løkke, Anders Catalán-Matamoros, Daniel Hilberg, Ole Bendstrup, Elisabeth Int J Environ Res Public Health Article We investigated the usefulness and effectiveness of tele-rehabilitation on exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A randomized study was carried out, including stable patients with IPF for 3 months of tele-rehabilitation: video and chat consultations with a physiotherapist and workout sessions with a virtual physiotherapist agent (VAPA). Moreover, 6-min walk test distance (6MWTD), forced vital capacity (FVC), diffusion capacity for carbon monoxide (DLCO), 7 days pedometry, Saint George Respiratory Questionnaire for interstitial lung disease, The King’s Brief Interstitial Lung Disease Questionnaire, and General Anxiety Disorder 7 Questionnaire were tested before and after 3 months of tele-rehabilitation, as well as after 3 and 6 months follow-up. Patient satisfaction and adherence were also measured for tele-rehabilitation with VAPA. Twenty-nine patients aged 70.9 ± 8.6 years, male 72.4%, FVC% 83.5 ± 17.7, DLCO% 50.6 ± 13.0, 6MWTD 468.4 ± 14.8 were included. Fifteen patients were randomized to tele-rehabilitation with VAPA and 14 to the control group. Differences in 6MWTD between groups were at baseline (+10 m (p = 0.11)) and after 3 (+39.5 m (p = 0.03)), 6 (+34.3 m (p = 0.02)), and 9 months (+40.5 m (p = 0.15)) follow-up. No difference was observed in pedometry and quality of life. Adherence was above 63%. Patient satisfaction was high. Tele-rehabilitation with VAPA appears to be useful in patients with IPF. Exercise capacity was better at follow up at 3 and 6 months compared with the control group. There was no change in quality of life or pedometry. Adherence and patient satisfaction were all high. MDPI 2021-09-23 /pmc/articles/PMC8508000/ /pubmed/34639313 http://dx.doi.org/10.3390/ijerph181910016 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cerdán-de-las-Heras, Jose Balbino, Fernanda Løkke, Anders Catalán-Matamoros, Daniel Hilberg, Ole Bendstrup, Elisabeth Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title | Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title_full | Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title_fullStr | Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title_full_unstemmed | Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title_short | Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial |
title_sort | tele-rehabilitation program in idiopathic pulmonary fibrosis—a single-center randomized trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508000/ https://www.ncbi.nlm.nih.gov/pubmed/34639313 http://dx.doi.org/10.3390/ijerph181910016 |
work_keys_str_mv | AT cerdandelasherasjose telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial AT balbinofernanda telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial AT løkkeanders telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial AT catalanmatamorosdaniel telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial AT hilbergole telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial AT bendstrupelisabeth telerehabilitationprograminidiopathicpulmonaryfibrosisasinglecenterrandomizedtrial |